Filing Details
- Accession Number:
- 0001140361-13-008208
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-19 19:23:33
- Reporting Period:
- 2013-02-14
- Filing Date:
- 2013-02-19
- Accepted Time:
- 2013-02-19 19:23:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1184151 | R Conan Deady | One Idexx Drive Westbrook ME 04092 | Corp Vp, General Counsel & Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-02-14 | 3,449 | $56.95 | 4,631 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-02-14 | 2,401 | $77.59 | 7,032 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-02-14 | 3,772 | $34.37 | 10,804 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-02-14 | 9,622 | $92.04 | 1,182 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-02-14 | 243 | $0.00 | 1,425 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-02-14 | 258 | $0.00 | 1,683 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-02-14 | 375 | $0.00 | 2,058 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-02-14 | 363 | $0.00 | 2,421 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-02-14 | 300 | $0.00 | 2,721 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-02-14 | 496 | $91.68 | 2,225 | No | 4 | F | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-02-14 | 1,693 | $0.00 | 1,693 | $56.95 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-02-14 | 2,401 | $0.00 | 2,401 | $77.59 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-02-14 | 3,772 | $0.00 | 3,772 | $34.37 |
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2013-02-14 | 1,756 | $0.00 | 1,756 | $56.95 |
Common Stock | Restricted Stock Unit | Disposition | 2013-02-14 | 243 | $0.00 | 243 | $0.00 |
Common Stock | Restricted Stock Unit | Disposition | 2013-02-14 | 258 | $0.00 | 258 | $0.00 |
Common Stock | Restricted Stock Unit | Disposition | 2013-02-14 | 375 | $0.00 | 375 | $0.00 |
Common Stock | Restricted Stock Unit | Disposition | 2013-02-14 | 363 | $0.00 | 363 | $0.00 |
Common Stock | Restricted Stock Unit | Disposition | 2013-02-14 | 300 | $0.00 | 300 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2015-02-13 | No | 4 | M | Direct | |
5,914 | 2018-02-13 | No | 4 | M | Direct | |
863 | 2016-02-13 | No | 4 | M | Direct | |
0 | 2015-02-13 | No | 4 | M | Direct | |
4,154 | No | 4 | M | Direct | ||
3,896 | No | 4 | M | Direct | ||
3,521 | No | 4 | M | Direct | ||
3,158 | No | 4 | M | Direct | ||
2,858 | No | 4 | M | Direct |
Footnotes
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $92.00 to $92.10, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Grant of options to buy shares of common stock becomes exercisable as to 3,449 shares on 02/14/2009 and 02/14/2010, 3,448 shares on 02/14/2011 and 02/14/2012, and the remaining 1,693 shares on 02/14/2013.
- Grant of options to buy shares of common stock becomes exercisable as to 2,401 shares on 02/14/2012, 02/14/2013, 02/14/2014 and 02/14/2015, and the remaining 1,112 shares on 02/14/2016.
- Grant of options to buy shares of common stock becomes exercisable as to 3,772 shares on 02/14/2010 and 02/14/2013, 3,773 shares on 02/14/2011 and 02/14/2012, and the remaining 863 shares on 02/14/2014.
- Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2011, and the remaining 1,755 shares on 02/14/2013.
- Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.
- Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.
- Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.
- Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.
- Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.